Buradasınız

Anasayfa » Content

Enalapril maleat'ın trombosit agregasyonu üzerine etkisi

The effect of Enalapril Maleate on Platelet Aggregation

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1994

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Twenty patients who applied and have been treated at Atatürk University Medical Faculty Internal Medicine Clinic have been included to this study. Enalapril maleate have also been given to 20 patients who have no bleeding diatesis in order to determine the effect on platelets. Ten days after treatment, thrombocyte aggregation of patients have been repeated. There was no significantly difference between before and after treatment with enalapril maleate (p 0.05). [Journal of Turgut Özal Medical Center 1(2): ir-!2i'.1994/
Bookmark/Search this post with
Abstract (Original Language): 
Hu çalışmaya Atatürk Üniversitesi Tıp Fakültesi İç Hastalıkları Polikliniğine başvuran veya kliniklerde yatan hipertansif 20 hasta alındı. Enalapril maleat'ın trombosit agregasyonu üzerine etkisini araştırmak amacıyla kanama diyatezi olmayan 20 hastaya enalapril maleat verildi. On gün süren tedavinin sonunda hastaların trombosit agregasyonu yenilendi. Enalapril maleate alan grupta trombosit agregasyonlarında anlamlı değişiklik görülmedi (p 0.05). I Turgut Özal Tıp Merkezi Dergisi 1(2): 117-121 ,1994]
FULL TEXT (PDF): 
PDF icon arastirmax-enalapril-maleatin-trombosit-agregasyonu-uzerine-etkisi.pdf
  • 2
117-121
  • Turkish

REFERENCES

References: 

1. Saunders RN. Platelets and Atherosclerosis. Progress in Drug Research 1985;29:49-62. 2 Garrivan JC, Peach MJ. Renin and angiotensin. In Gilmon AG, Roll TW, Nies AS, Taylor PC. (eds): The Pharniocological basis of therapeutics. 8th edition, Pergamon press, NewYork 1980:743-63. 3. Operator's Reference Manual: Cell-Dyn 1500 Automoted Hematology Analyzer, Sequoia turner Cooparation, 1986.4. British Society for Haematology: Guidlines on platelet function testing. J Clin Pathol 1988;41:322¬30.
5. Stehbens WE: Relationship of coronary artery thrombosis to myocardial infarction. Lancet 1985;2:639-42.
6. De caterio R, Lambardini M, Bernini W, Mazzone A: inhibition of platelet function during invivo infusion of isosorbid mononitrates: Relationship between plasma drug concentration and hemodynamic effects. Am. Heart Journal 1990; April:855-62.
7. Nyrop M, Zweifler AJ: Platelet aggregation in hypertansion and the effects of anti-hypertansive treatment. J Hypertansion 1988;6:263-9.
8. Decaterino R, Gionnesi D, Boem A, Bernini W: Equal antiplatelet effects of aspirin 50 or 324 mg/day
in patients after acute myocadial infarction. Thrombosis and Hemostasis 1985;54(2):528-32.
9. Ring M, Corrigan J, Fenster PE: Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin. Thrombocyt Research 1986;44:391-400.
10. Gupha RK, Kjeldsen SE, Motley E, Weber AB, Zweifler AJ, Julius S: Platelet function during antihypertansive treatment with quinapril, a novel angiotensin converting enzyme inhibitor. Journal of Cardiovascular Pharmacology 1986; 17:13-19.
11. Greer IA, Walker JJ, Colder AA, Forbes CD: Aspirin with an adrenergic or a calcium chanel blocking agent as new combination therapy for arterial thrombosis. Lancet 1991;February:351-2.
12. De Clerck F: Blood platelets in human essential hypertansion agents. Actions 1986;18:563-80.

Thank you for copying data from http://www.arastirmax.com